M. Louis Handoko

Cardiologist (heart failure) #Cardio #HFpEF @AmsterdamUMC @UZH_en #PCHF @Oxford_NDPH #ClinicalTrials

[M. Louis Handoko @MLHandoko]

@aayshacader Hi Aaysha, I was great meeting you! Looking forward seeing you in June. Gr. Louis

[M. Louis Handoko @MLHandoko]

After hearing about EMPEROR-PRESERVED: need a simple practical guide to initiate SGLT2 inhibitors? check: https://t.co/KdLBhhIJ40 #ESCCongress2021

[M. Louis Handoko @MLHandoko]

An original analysis that underscores the relevance to maintain sinus rhythm in patients with underlying HFpEF by Wagemakers et al. https://t.co/NldB4kKUkx #HFpEF #ESCCongress2021

[M. Louis Handoko @MLHandoko]

HFpEF patients are vulnerable! Several factors identified that predict rehospitalizations in a large HFpEF-cohort by Schrutka et al. https://t.co/gZFmyzJ3pv #ESCCongress2021

[M. Louis Handoko @MLHandoko]

High IL-6 levels associated with adverse outcome in HFpEF: a potential treatment target? by Mooney et al. https://t.co/7gbnQIT55n #ESCCongress

[M. Louis Handoko @MLHandoko]

EMPEROR-PRESERVED: a true landmark trial for HFpEF! #ESCCongress2021 https://t.co/emOwqptaH5